These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Today's treatment of chronic duodenal ulcer. H2 antagonists and the role of surgery. Clark CG Practitioner; 1983 Apr; 227(1378):543-6. PubMed ID: 6134276 [No Abstract] [Full Text] [Related]
23. [Pharmacology and clinical effects of acid determination in ulcer hemorrhage]. Schepp W Bildgebung; 1993 Apr; 60 Suppl 1():41-4. PubMed ID: 8104063 [No Abstract] [Full Text] [Related]
24. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists]. Contraşiu P; Calinici V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650 [No Abstract] [Full Text] [Related]
25. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist]. Müller P; Dammann HG; Simon B Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147 [No Abstract] [Full Text] [Related]
26. [New antisecretory drugs in the treatment of ulcer]. Sheptulin AA Klin Med (Mosk); 1994; 72(1):12-5. PubMed ID: 7910870 [No Abstract] [Full Text] [Related]
28. Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters. Am J Gastroenterol; 1988 Jun; 83(6):607-17. PubMed ID: 2897783 [No Abstract] [Full Text] [Related]
29. Another look at peptic ulcer. Piper DW; Barr GD Aust Fam Physician; 1981 Aug; 10(8):636-40. PubMed ID: 6117272 [No Abstract] [Full Text] [Related]
30. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 4: Pharmacological basis and therapy with H2 antagonist]. Med Welt; 1983 Dec; 34(49):20, 22. PubMed ID: 6140616 [No Abstract] [Full Text] [Related]
31. [Epidemiological behavior of perforated peptic ulcer before and after the introduction of the antisecretory drug therapy. Our experience]. Sacco R; Giovanelli A; Giuliano L; Piazzalunga D; Poletti EM; Arrigoni F; Cassinelli GB Minerva Chir; 1995 Oct; 50(10):871-8. PubMed ID: 8684634 [TBL] [Abstract][Full Text] [Related]
33. [H2 blockers in the treatment of bleeding gastroduodenal ulcers]. Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821 [No Abstract] [Full Text] [Related]
34. Medical and surgical treatment of chronic gastric ulcer. Kelly KA; Malagelada JR Clin Gastroenterol; 1984 May; 13(2):621-34. PubMed ID: 6146418 [No Abstract] [Full Text] [Related]
35. Eradication treatment for Helicobacter pylori in general practice. Fraser AG; Moore L; Berry S; Arroll B N Z Med J; 1996 Nov; 109(1033):422-4. PubMed ID: 8941293 [TBL] [Abstract][Full Text] [Related]
36. Ranitidine in the treatment of acute upper gastrointestinal haemorrhage--a comparative study. Preliminary report. Nowak A; Sadliński C; Górka Z; Nowakowska E; Rudzki J; Gibiński K Hepatogastroenterology; 1981 Oct; 28(5):267-9. PubMed ID: 6124495 [TBL] [Abstract][Full Text] [Related]
37. [Surgical treatment of ulcer disease 5 years before and after the introduction of cimetidine]. Rohner HG; Blömer A; Echterhoff HM; Gugler R Z Gastroenterol; 1983 Oct; 21(10):585-92. PubMed ID: 6649737 [TBL] [Abstract][Full Text] [Related]
38. [An inquiry on ulcer surgery in Sweden 1956-1986: continuous decline in ventricular and duodenal ulcer surgery]. Gustavsson S; Nyren O Lakartidningen; 1989 Oct; 86(40):3357-8, 3361. PubMed ID: 2796522 [No Abstract] [Full Text] [Related]
39. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!]. Vallot T; Mignon M Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433 [No Abstract] [Full Text] [Related]
40. [Acid anti-secretion therapy in gastric and duodenal ulcer]. Lattanzi A Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]